Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 540,856 | 578,929 | 1,347,186 | 1,526,606 | 647,278 |
| Marketable Securities | 392,888 | N/A | N/A | N/A | 157,649 |
| Receivables | 108,285 | 297,240 | 82,375 | 454,993 | 262,012 |
| Inventories | 8,749 | 41,696 | 36,683 | 8,872 | N/A |
| TOTAL | $1,128,942 | $1,143,888 | $1,703,391 | $2,155,119 | $1,248,203 |
| Non-Current Assets | |||||
| PPE Net | 138,413 | 305,771 | 294,247 | 225,741 | 179,954 |
| Intangibles | 107,478 | 127,454 | 126,331 | 131,479 | 141,104 |
| Other Non-Current Assets | 185,585 | 220,377 | 134,710 | 64,414 | 13,218 |
| TOTAL | $431,476 | $653,602 | $555,288 | $421,634 | $334,276 |
| Total Assets | $1,560,418 | $1,797,490 | $2,258,679 | $2,576,753 | $1,582,479 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,579 | 132,610 | 216,517 | 127,050 | 54,332 |
| Accrued Expenses | 211,165 | 394,668 | 591,158 | 673,731 | 137,390 |
| Other current liabilities | 219,596 | 861,408 | 930,055 | 36,061 | 8,860 |
| TOTAL | $1,154,416 | $1,635,138 | $2,459,944 | $2,390,319 | $579,672 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 675,067 | 241,310 | 370,137 | 1,422,944 | 273,228 |
| Other Non-Current Liabilities | 529,298 | 201,146 | 222,161 | 365,579 | 335,515 |
| TOTAL | $1,029,843 | $879,279 | $432,813 | $538,107 | $375,598 |
| Total Liabilities | $2,184,259 | $2,514,417 | $2,892,757 | $2,928,426 | $955,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,844 | 139,953 | 86,173 | 76,283 | 73,859 |
| Common Shares | 1,619 | 1,405 | 868 | 764 | 714 |
| Retained earnings | -5,008,450 | -4,820,951 | -4,275,889 | -3,617,950 | -1,874,199 |
| Other shareholders' equity | -22,413 | 2,455 | -6,036 | -1,454 | 7,218 |
| TOTAL | $-623,841 | $-716,927 | $-634,078 | $-351,673 | $627,209 |
| Total Liabilities And Equity | $1,560,418 | $1,797,490 | $2,258,679 | $2,576,753 | $1,582,479 |